Comparison of the bactericidal effects of quinolones against low-susceptible Haemophilus influenzae

References

1. Kakuta R, Yano H, Hidaka H, Kanamori H, Endo S et al. Molecular epidemiology of ampicillin-resistant Haemophilus influenzae causing acute otitis media in Japanese infants and young children. Pediatr Infect Dis J 2016; 35:501–506 [View Article] [PubMed]
   [Google Scholar]
2. Park C, Kim KH, Shin NY, Byun JH, Kwon EY et al. Genetic diversity of the ftsI gene in beta-lactamase-nonproducing ampicillin-resistant and beta-lactamase-producing amoxicillin-/clavulanic acid-resistant nasopharyngeal Haemophilus influenzae strains isolated from children in south korea. Microb Drug Resist 2013; 19:224–230 [View Article] [PubMed]
   [Google Scholar]
3. Ouchi K, Sunakawa K. Effect of new oral antimicrobial agents in outpatient treatment of pneumonia in children. Jpn J Antibiotics 2014; 67:157–166
   [Google Scholar]
4. Morozumi M, Chiba N, Okada T, Sakata H, Matsubara K et al. Antibiotic susceptibility in relation to genotype of Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae responsible for community-acquired pneumonia in children. J Infect Chemother 2013; 19:432–440 [View Article] [PubMed]
   [Google Scholar]
5. Tanaka T, Oishi T, Miyata I, Wakabayashi S, Kono M et al. Macrolide-resistant Mycoplasma pneumoniae infection, Japan, 2008-2015. Emerg Infect Dis 2017; 23:1703–1706 [View Article] [PubMed]
   [Google Scholar]
6. Shoji H, Shirakura T, Fukuchi K, Takuma T, Hanaki H et al. A molecular analysis of quinolone-resistant Haemophilus influenzae: Validation of the mutations in quinolone resistance-determining regions. J Infect Chemother 2014; 20:250–255 [View Article] [PubMed]
   [Google Scholar]
7. Seyama S, Wajima T, Yanagisawa Y, Nakaminami H, Ushio M et al. Rise in Haemophilus influenzae with reduced quinolone susceptibility and development of a simple screening method. Pediatr Infect Dis J 2017; 36:263–266 [View Article] [PubMed]
   [Google Scholar]
8. Tanaka E, Hara N, Wajima T, Ochiai S, Seyama S et al. Emergence of Haemophilus influenzae with low susceptibility to quinolones and persistence in tosufloxacin treatment. J Glob Antimicrob Resist 2019; 18:104–108 [View Article] [PubMed]
   [Google Scholar]
9. CLSI Performance Standards for Antimicrobial Susceptibility Testing, 29th ed. Wayne, PA: CLSI; 2019
   [Google Scholar]
10. Hara N, Wajima T, Tanaka E, Noguchi N, Shirai A et al. Two cases in which tosufloxacin was administered for respiratory infections that may have been caused by Haemophilus influenzae less susceptible to quinolone. Jpn J Pharm Health Care Sci 2020; 46:211–214
    [Google Scholar]
11. Tanaka E, Wajima T, Hara N, Shirai A, Shibata M et al. First outbreak of Haemophilus influenzae clone ST422 with low susceptibility to quinolones in paediatric patients in japan. J Med Microbiol 2020; 69:239–243 [View Article] [PubMed]
    [Google Scholar]
12. Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 2013; 48:452–458 [View Article] [PubMed]
    [Google Scholar]